Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

SML0338

Sigma-Aldrich

Lornoxicam

≥98% (HPLC)

Synonym(s):

6-Chloro-4-hydroxy-2-methyl-N-2-pyridinyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxamide 1,1-dioxide, Chlortenoxicam, Ro 13-9297, TS 110

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C13H10ClN3O4S2
CAS Number:
70374-39-9
Molecular Weight:
371.82
MDL number:
MFCD00866163
UNSPSC Code:
12352200
PubChem Substance ID:
329825343
NACRES:
NA.77
Pricing and availability is not currently available.

Quality Level

100

Assay

≥98% (HPLC)

form

powder

color

faintly yellow to dark yellow

solubility

DMSO: >5 mg/mL (warmed)

storage temp.

−20°C

SMILES string

CN1C(C(=O)Nc2ccccn2)=C(O)c3sc(Cl)cc3S1(=O)=O

InChI

1S/C13H10ClN3O4S2/c1-17-10(13(19)16-9-4-2-3-5-15-9)11(18)12-7(23(17,20)21)6-8(14)22-12/h2-6,18H,1H3,(H,15,16,19)

InChI key

WLHQHAUOOXYABV-UHFFFAOYSA-N

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
HPA064755HPA074638SAB4500890
Anti-FGA antibody produced in rabbit Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution

HPA051370

Anti-FGA antibody produced in rabbit

Anti-FGA antibody produced in rabbit Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution

HPA064755

Anti-FGA antibody produced in rabbit

Anti-FGG antibody produced in rabbit Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution

HPA074638

Anti-FGG antibody produced in rabbit

Anti-FGR antibody produced in rabbit affinity isolated antibody

SAB4500890

Anti-FGR antibody produced in rabbit

conjugate

unconjugated

conjugate

unconjugated

conjugate

unconjugated

conjugate

unconjugated

antibody form

affinity isolated antibody

antibody form

affinity isolated antibody

antibody form

affinity isolated antibody

antibody form

affinity isolated antibody

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

product line

Prestige Antibodies® Powered by Atlas Antibodies

product line

Prestige Antibodies® Powered by Atlas Antibodies

product line

Prestige Antibodies® Powered by Atlas Antibodies

product line

-

technique(s)

immunohistochemistry: 1:1000- 1:2500

technique(s)

immunohistochemistry: 1:1000- 1:2500

technique(s)

immunofluorescence: 0.25-2 μg/mL (ICC-IF), western blot: 0.04-0.4 μg/mL

technique(s)

ELISA: 1:40000, western blot: 1:500-1:1000

General description

Lornoxicam belongs to the oxicam class. It has anti-inflammatory and antipyretic properties. Lornoxicam prevents the synthesis of prostaglandin (PG) by inhibiting cyclo-oxygenase. It is used to relieve various types of symptoms associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute sciatica and low back pain.[1]

Application

Lornoxicam has been used as a drug in melanin binding study with cassette dosing and rapid equilibrium dialysis inserts.[2]

Biochem/physiol Actions

Lornoxicam is an oxicam-class NSAID with strong analgesic properties.
Lornoxicam is an oxicam-class NSAID; cyclooxygenase inhibitor.

Pictograms

Skull and crossbones
GHS06

Signal Word

Danger

Hazard Statements

H300

Hazard Classifications

Acute Tox. 2 Oral

Storage Class Code

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number
    042M4754V

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Search for a COA

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Zhiyue Zhang et al.
    Drug delivery, 19(5), 255-263 (2012-07-11)
    The aim of this study was to investigate the joint tissue distribution and pharmacodynamics of Lornoxicam (Lnxc) following intra-articular injection of either Lnxc suspensions or sustained release Lnxc-loaded PLGA microspheres (Lnxc-MS), as well as the biocompatibility of PLGA microspheres with
    Nilüfer Bölükbasi et al.
    European journal of oral implantology, 5(2), 165-173 (2012-08-07)
    To assess the efficacy of quick-release lornoxicam (LNX) on patient-reported acute pain after dental implant surgery. The study included subjects in good general health, aged 18 to 65 and scheduled to receive a maximum of three implants in the same
    Hany A Mowafi et al.
    World journal of surgery, 36(9), 2039-2044 (2012-05-16)
    The aim of this prospective, randomized, double-blind study was to determine the more effective supplemental analgesic, paracetamol or lornoxicam, for postoperative pain relief after lower abdominal surgery. Sixty patients scheduled for lower abdominal surgery under general anesthesia were randomly allocated
    M Arslan et al.
    Bratislavske lekarske listy, 113(4), 211-213 (2012-04-17)
    Lornoxicam and iv paracetamol are commonly preferred to be used for postoperative analgesia. Although Aspirin is a well known non-steroid anti-inflammatory drug that decreases the erythrocyte deformability, there is no study comparing lornoxicam and iv paracetamol regarding their effects on
    Jianjun Zhang et al.
    Pakistan journal of pharmaceutical sciences, 25(2), 371-375 (2012-03-31)
    A rapid, isocratic stability indicating high performance liquid chromatographic method was developed and validated for the estimation of lornoxicam in its powder for injection. The analysis was performed on a Shimadzu VP-ODS (4. 6 mm x 15 cm, 5 µm)
    View All Related Papers

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service